Tedco awards $600K to tech firms - Washington Business Journal:

ejoxot.wordpress.com
The money was granted in collaboration withthe U.S. Army Medicalk Research and Materiel Command and the throughhthe Ft. Detrick Technologyu Transfer Initiative. The purpose of the technology transfet program is to raise awareness of new and developinbg technologies and funding them to transition as viable projectsfor follow-on funding in the markegt place. Each company that receivex funding was awardedapproximately $50,000 between Marcyh 2008 and May 2009, making up the initiative’w second round of financial awards since its $750,000 program extension. The fundws for the program’s second phasre were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscoe G. Bartlett, R-Md.
“The [Ft. Detrick Technologyy Transfer Initiative] program is enablin area businesses to harness the technologies being developer at Fort Detrick and apply them to thecommercial sector,” said Mikulski. “This will lead to new productds that have the power to create jobs and save Mikulski announced the firsft phase of the tech transfer program in March 2005 when 11 companie sreceived funding. in Rockville: The company is developing a healthj care technology called miTag which is a scalablde wireless sensor solution for improvinghpatient flow.
in Frederick: The company is developing a technologyg called the GeNova Screento identify, isolate, and producd antibody-like molecules. in Rockville: The company is developinb an on-demand biotech products including a combination vaccine against plaguand anthrax. BioAssay Works LLC in Ijamsville: The companu is developing a lateral-flow visual diagnostic test to detect and differentiatde single sample multiplepathogenic poxviruses, includinbg variola, vaccinia, and monkeypox. in The company is safety-testing a medicap product called ClotFoam, which is a non-compressible, intracavitary hemostatic agent.
CynerGene IDMP in The companyis developing, validatinyg and implementing a supplementakl diagnosis of Malaria, HIV, and Dengus using its Infectious Disease Multiplex Panel approach, whicb could allow for creation of biosensors. LLC in Baltimore: The companyu is developing required components and system framework to enabler conversational interfaces fortelemedicine tools. Such toole would allow professional medics touse voice, and other human-- computer interactions to access and document informationh in electronic medical records. in Rockville: The company is developing technology to preserve mammalian cells in dries format that can easilyybe re-hydrated for a variety of uses.
LLC in The company is evaluating the effecr of Imagilin patented probiotics as a food supplemengt to enhance the immune responsivenesxs of guinea pigs upon immunization or challenge with virulent The evaluation will suggest the ability of Imagilin patentee probiotics to enhance the immunization of a in Baltimore: The company is developingg micropatterned substrates for vira infectivity assays. Juxtopia in The company is customizing its Wearablre Assistance and Situational Awareness goggles and service toallow U.S. Army combagt medics to access and document information to electrica medical recordsvia hands-free voice-requests and voice-responses.
in The company is developing cell therapiesd to treat brain and spinalcord